ES2157435T3 - Particulas retroviricas pseudotipadas. - Google Patents

Particulas retroviricas pseudotipadas.

Info

Publication number
ES2157435T3
ES2157435T3 ES96909135T ES96909135T ES2157435T3 ES 2157435 T3 ES2157435 T3 ES 2157435T3 ES 96909135 T ES96909135 T ES 96909135T ES 96909135 T ES96909135 T ES 96909135T ES 2157435 T3 ES2157435 T3 ES 2157435T3
Authority
ES
Spain
Prior art keywords
pseudotipated
retroviral vector
retroviric
particles
mlv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96909135T
Other languages
English (en)
Inventor
Brian Salmons
Jorg Baumann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Austrian Nordic Biotherapeutics AG
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Original Assignee
Austrian Nordic Biotherapeutics AG
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Austrian Nordic Biotherapeutics AG, Helmholtz Zentrum Muenchen Deutsches Forschungszentrum fuer Gesundheit und Umwelt GmbH filed Critical Austrian Nordic Biotherapeutics AG
Application granted granted Critical
Publication of ES2157435T3 publication Critical patent/ES2157435T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051—Methods of production or purification of viral material
    • C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Eye Examination Apparatus (AREA)
  • Optical Radar Systems And Details Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN SISTEMA DE VECTOR RETROVIRAL QUE COMPRENDE UNA LINEA CELULAR DE EMPAQUETAMIENTO QUE SINTETIZA EL CORE Y LAS PROTEINAS ENZIMATICAS DEL VIRUS MLV A PARTIR DE UNO O VARIOS CONSTRUCTOS QUE CONTIENEN GAG Y POL, Y LA ENVUELTA DEL VIRUS MMTV A PARTIR DEL MISMO CONSTRUCTO O UN CONSTRUCTO INDEPENDIENTE QUE CONTIENE ENV, Y A PARTICULAS RETROVIRALES PSEUDOTIPADAS PRODUCIDAS CULTIVANDO DICHO SISTEMA DE VECTOR RETROVIRAL TRANSFECTADO CON UN VECTOR RETROVIRAL BASADO EN MLV, Y AL AISLAMIENTO DE DICHAS PARTICULAS RETROVIRALES PSEUDOTIPADAS.
ES96909135T 1995-03-29 1996-03-27 Particulas retroviricas pseudotipadas. Expired - Lifetime ES2157435T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK32795 1995-03-29

Publications (1)

Publication Number Publication Date
ES2157435T3 true ES2157435T3 (es) 2001-08-16

Family

ID=8092296

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96909135T Expired - Lifetime ES2157435T3 (es) 1995-03-29 1996-03-27 Particulas retroviricas pseudotipadas.

Country Status (8)

Country Link
EP (1) EP0817860B1 (es)
JP (1) JPH11502706A (es)
AT (1) ATE200912T1 (es)
AU (1) AU5274696A (es)
DE (1) DE69612660T2 (es)
DK (1) DK0817860T3 (es)
ES (1) ES2157435T3 (es)
WO (1) WO1996030533A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11507244A (ja) * 1995-10-05 1999-06-29 カイロン コーポレイション Ｓｒｖ−３エンベロープ糖タンパク質配列で偽型化したレトロウイルスベクター
DK0975783T3 (da) * 1997-02-27 2002-01-28 Bundesrepublik Deutschland Let Retrovirusvektorer, fremgangsmåde til fremstilling heraf samt deres anvendelse til genoverføring til CD4-positive celler
WO1998053063A2 (en) * 1997-05-16 1998-11-26 Leuven Research & Development Vzw Mammalian cell transduction for use in gene therapy
EP0938904A1 (en) * 1998-02-09 1999-09-01 Leuven Research & Development vzw Mammalian cell transduction for use in gene therapy
FR2779445B1 (fr) * 1998-06-08 2000-08-11 Univ Nantes Kit d'encapsidation
GB0400443D0 (en) 2004-01-09 2004-02-11 Oxford Biomedica Ltd Cascade
WO2003025191A2 (en) * 2001-09-21 2003-03-27 Oxford Biomedica (Uk) Limited Pseudotyped retroviral vector system
CN121605184A (zh) * 2023-07-20 2026-03-03 香港北恒生物科技有限公司 逆转录病毒包装细胞及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU680508B2 (en) * 1993-04-06 1997-07-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Gibbon ape leukemia virus-based retroviral vectors

Also Published As

Publication number Publication date
WO1996030533A1 (en) 1996-10-03
EP0817860A1 (en) 1998-01-14
DE69612660T2 (de) 2002-04-18
ATE200912T1 (de) 2001-05-15
DE69612660D1 (de) 2001-06-07
JPH11502706A (ja) 1999-03-09
AU5274696A (en) 1996-10-16
EP0817860B1 (en) 2001-05-02
DK0817860T3 (da) 2001-10-01

Similar Documents

Publication Publication Date Title
DE69734605D1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
ES2153654T3 (es) Vectores retrovirales.
ATE520783T1 (de) Lentivirale vektoren
ZA200603731B (en) Plasmid system for multiple expression
BR9812720A (pt) Método de processamento de informação usando um assistente de comunicação pessoal
TR199701252T1 (xx) Bir saponin ve bir sterol i�eren a��lar.
HUP0301659A2 (hu) Kukorica cellulóz-szintetázok és alkalmazásuk
ES2160191T3 (es) Deteccion de listerias, mediante bacteriofagos recombinantes.
GT199400073A (es) Sistema de anuncios por telefono publitel internacional
WO2007038142A3 (en) Sms+: short message service plus context support for social obligations and sms+4d: short message service plus 4-dimensional context
ES2157435T3 (es) Particulas retroviricas pseudotipadas.
DE3750125D1 (de) Biologische eindämmung.
ATE186738T1 (de) Kohlenhydratmodifizierte cytostatika
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
ATE244762T1 (de) Säugetier - expressionssysteme für hüllenprotingene des hepatitit - c - virus
EP1002276A4 (en) MESSAGE SELECTED BY THE SUPPLIER IN RESPONSE TO A USER REQUEST
TR200000697T2 (tr) İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları.
WO2003016491A3 (en) Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
DE60031369D1 (de) Replikation -defektive baculoviren expressionssystem
ATE465754T1 (de) Nicht-immunsuppresives hiv tat-protein
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
AU8405798A (en) A swine hepatitis e virus and uses thereof
PT870015E (pt) Novas xilanases os genes que as codificam e as suas utilizacoes
DE69823188D1 (de) Klonierung der udp-galaktose-epimerase
TR199901862T2 (xx) Yeni Bile�ikler.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 817860

Country of ref document: ES